Designing and evaluating a new smart immunotoxins for targeting cancerous nerve cells
Journal of Cellular Immunotherapy · 2015
DOI: 10.1016/j.jocit.2015.10.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Immunotherapy, 2015. Verfasst von Shabnam Ensandoost und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
miRNAs have been described as oncogenes or tumor suppressors and many of them are used for diagnosis and as prognostic or predictive tools.But till now, two challenges are remained that requires further study: (i) the safety profile of miRNAs and (ii) clinic delivery.Fig. 1.PubMed query for miRNAs and cancer (September 2015).
Zitieren
APA
Ensandoost, S., & Haddad-Mashadrizeh, A. (2015). Designing and evaluating a new smart immunotoxins for targeting cancerous nerve cells. Journal of Cellular Immunotherapy. https://doi.org/10.1016/j.jocit.2015.10.012
Vancouver
Ensandoost S, Haddad-Mashadrizeh A. Designing and evaluating a new smart immunotoxins for targeting cancerous nerve cells. Journal of Cellular Immunotherapy. 2015. doi:10.1016/j.jocit.2015.10.012
BibTeX
@article{Ensandoost2015,
author = {Ensandoost, Shabnam and Haddad-Mashadrizeh, Aliakbar},
title = {Designing and evaluating a new smart immunotoxins for targeting cancerous nerve cells},
journal = {Journal of Cellular Immunotherapy},
year = {2015},
doi = {10.1016/j.jocit.2015.10.012}
}
EUVIMED